Nektar Therapeutics

NKTR
Delayed Nasdaq - 09/20 10:00:00 pm
20.15USD
-0.35%
Upcoming events on NEKTAR THERAPEUTICS
10/09/19 | 03:00pm Oxford Global Advances In Immuno-Oncology USA Congress
10/20/19 American Pharmacometrics Conference
11/11/19 Q3 2019 Earnings Release (Projected)
02/25/20 FY 2019 Earnings Release (Projected)
Past events on NEKTAR THERAPEUTICS
09/11/19 | 06:18pmCAR-TCR Summit
08/08/19 | 05:00pmInterim 2019 Earnings Call
08/08/19 | 04:16pmInterim 2019 Earnings Release
08/05/19Cambridge Healthtech Institute Immuno Oncology Summit
Upcoming sector events for NEKTAR THERAPEUTICS
09/21/19 | 02:30am BEIGENE LTD : Chinese Society of Clinical Oncology Meeting - Innovative Drug Clinical Data Session 1
09/23/19 CHARLES RIVER LABORATORIES INTL. INC : World Congress
09/24/19 QIAGEN NV : Berenberg Goldman Sachs German Corporate Conference
09/25/19 | 09:00pm PEPTIDREAM INC : Annual General Meeting
Past sector events for NEKTAR THERAPEUTICS
09/20/19 | 11:38pmBEIGENE LTD : Chinese Society of Clinical Oncology Meeting - Lung Cancer Session 3
09/20/19BEIGENE LTD : Chinese Society of Clinical Oncology Meeting - Poster - 46
09/20/19BEIGENE LTD : Chinese Society of Clinical Oncology Meeting - Poster - 60
09/19/19 | 11:24pmBEIGENE LTD : Chinese Society of Clinical Oncology Meeting - Advanced Gastric Cancer Session 3
Annual results
Annual results20182019 (e)
Sales
M $
Released
Forecast
Spread
1 193
1 180
1,1%

106
Operating income
(EBITDA)
M $
Released
Forecast
Spread
699
684
2,1%

-496
Operating profit
(EBIT)
M $
Released
Forecast
Spread
688
675
2,0%

-505
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
683
668
2,3%

-511
Net income
M $
Released
Forecast
Spread
681
664
2,6%

-504
EPS
 $
Released
Forecast
Spread
3,78
3,75
0,70%

-2,88
Announcement Date02/28/2019

Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise